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Abstract
Background: Insulin resistance induced by a high fat diet has been associated with alterations in
lipid content and composition in skeletal muscle and adipose tissue. Administration of β3-
adrenoceptor (β3-AR) agonists was recently reported to prevent insulin resistance induced by a
high fat diet, such as the cafeteria diet. The objective of the present study was to determine
whether a selective β3-AR agonist (ZD7114) could prevent alterations of the lipid profile of skeletal
muscle and adipose tissue lipids induced by a cafeteria diet.
Methods: Male Sprague-Dawley rats fed a cafeteria diet were treated orally with either the β3-
AR agonist ZD7114 (1 mg/kg per day) or the vehicle for 60 days. Rats fed a chow diet were used
as a reference group. In addition to the determination of body weight and insulin plasma level, lipid
content and fatty acid composition in gastronemius and in epididymal adipose tissue were
measured by gas-liquid chromatography, at the end of the study.
Results: In addition to higher body weights and plasma insulin concentrations, rats fed a cafeteria
diet had greater triacylglycerol (TAG) and diacylglycerol (DAG) accumulation in skeletal muscle,
contrary to animals fed a chow diet. As expected, ZD7114 treatment prevented the excessive
weight gain and hyperinsulinemia induced by the cafeteria diet. Furthermore, in ZD7114 treated
rats, intramyocellular DAG levels were lower and the proportion of polyunsaturated fatty acids,
particularly arachidonic acid, in adipose tissue phospholipids was higher than in animals fed a
cafeteria diet.
Conclusions: These results show that activation of the β3-AR was able to prevent lipid alterations
in muscle and adipose tissue associated with insulin resistance induced by the cafeteria diet. These
changes in intramyocellular DAG levels and adipose tissue PL composition may contribute to the
improved insulin sensitivity associated with β3-AR activation.
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Background
Dietary fatty acids are known to influence the composi-
tion of stored triacylglycerol (TAG) and membrane phos-
pholipids (PL) in adipose tissue [1]. More recently, it was
demonstrated that the lipid profile in skeletal muscle
reflected dietary lipids [2-4]. Furthermore, the modifica-
tions of fatty acid concentrations and composition in tis-
sue lipids induced by a high fat diet has been associated
with alterations in lipid metabolism and insulin sensitiv-
ity [5,6]. Indeed, enrichment of membrane PL with satu-
rated fatty acids (SFA) was able to impair insulin action in
skeletal muscle and adipose tissue, whereas a higher pro-
portion of polyunsaturated fatty acids (PUFA) improved
insulin sensitivity in these tissues [7-9]. TAG accumula-
tion in skeletal muscle was also correlated with the devel-
opment of insulin resistance, independent to the degree
of obesity [10-13]. Intramyocellular TAG could represent
only a marker of insulin resistance whereas intracellular
accumulation of long chain acyl-coenzyme A, ceramide or
diacylglycerol (DAG) were reported to directly alter the
insulin action [14].
Chronic activation of the β3-adrenoceptor (β3-AR), which
is predominantly expressed in white and brown adipose
tissue, by selective agonists exerts both anti-obesity and
anti-diabetic effects in rodent models of obesity [15,16].
Activation of this receptor has been reported to enhance
energy expenditure via stimulation of thermogenesis in
brown adipose tissue [16]. The improvement in glucose
homeostasis induced by β3-AR agonists appears to be a
consequence of increased insulin sensitivity in peripheral
tissues rather than stimulation of insulin secretion by the
pancreas [17]. Although, the expression of β3-AR in myo-
cytes is still a matter of debate [18-20], obese rats treated
with β3-AR agonists demonstrated an improvement of
insulin sensitivity in brown and white adipose tissue as
well as in skeletal muscle [17,21,22]. In adipose tissue this
effect is believed to be mediated by the conversion of large
adipocytes into small adipocytes, which are more sensi-
tive to insulin [21]. In skeletal muscle, it seems more
likely that the effects of β3-AR agonists on insulin sensitiv-
ity are mediated by alternate indirect mechanisms.
The objective of the present study was to determine
whether a selective β3-AR agonist could prevent altera-
tions in the profile of skeletal muscle and adipose tissue
lipids induced with the consumption of the cafeteria diet,
previously reported to induce weight gain and hyperin-
sulinemia [22,23]. The selective β3-AR agonist ZD7114
was used in this study. When administered at 1 mg/kg/
day, this compound has been shown to increase thermo-
genesis in rodents and dogs without increasing heart rate
or β2-AR-mediated effects such as tremor [24]. ZD7114
pharmacological specificity was also demonstrated in
brown adipocytes and smooth muscles [25,26]. As
expected, we observed that a chronic treatment with the
ZD7114 prevented the development of excessive fat mass
and hyperinsulinemia induced by this diet. These preven-
tive beneficial effects exerted by the β3-AR agonist were
associated with a reduction of muscle DAG accumulation.
In adipose tissue, ZD7114 treatment was able to limit the
proportional reduction of PUFA into the PL pool, induced
by the cafeteria diet. Our results indicate that a β3-AR ago-
nist prevents some cafeteria diet-induced alterations of
the fatty acid profile of lipids in skeletal muscle and adi-
pose tissue. Furthermore, we propose that these changes
may contribute to the improved of insulin sensitivity
observed in rats treated with a β3-AR agonist during the
development of obesity.
Methods
Animal study
Male Sprague-Dawley rats were purchased from Charles
River (L'arbesles, France) at 5–6 weeks of age. Animals
were individually housed in temperature-controlled
rooms (22°C) with a 12-h light-dark cycle. Ten days
before the beginning of the study, 30 rats were provided a
normal chow diet (Kliba-Nafalg, Switzerland) and free
access to drinking water. At the end of this period, rats
were weighed and pre-selected for their sensitivity to
weight gain (i.e. rat presenting at least 35% weight gain
after a 10-day selection period). The selected rats (n = 15)
were equally randomized into 3 groups. A reference
group, consisted of rats fed for 60 days with a standard
pellet chow diet containing 28, 57 and 15% E from pro-
tein, carbohydrate and fat, respectively (REF group). The
remaining rats were fed for 60 days with a cafeteria diet
composed of 30 g of a mix containing salami, cookies,
cheese, sausage, chips, chocolate and almonds in a pro-
portion of 2:2:2:1:1:1:1 and 30 g of the reference group
chow diet. This mixed diet contained 26, 27 and 47%
energy as protein, carbohydrate and fat, respectively. At
the beginning of the dietary intervention, both groups fed
the cafeteria diet received daily, by gavage (0.5 ml/100 g
body weight), either the selective β-3AR agonist ZD7114
at 1 mg/kg per day (CAF-ZD group) or water alone (CAF
group) until day 60. Rats from the REF group (chow diet)
also received a daily gavage of water (0.5 ml/100 g body
weight).
Body weight and food intake were recorded daily. Rats
were fasted for 8 hours before sacrifice, performed under
isoflurane anaesthesia. Tissues were immediately col-
lected, weighed, frozen in liquid nitrogen and kept at -
80°C until analysed.
All procedures in the study were in compliance with the
ethical committee of the "Service vétérinaire du canton de
Vaud".Nutrition & Metabolism 2004, 1:4 http://www.nutritionandmetabolism.com/content/1/1/4
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Estimation of the proportions of the different lipid classes
contained in the cafeteria diet (see Discussion) was per-
formed using the USDA Nutrient Database.
Lipid fatty acid composition
Adipose tissue
Fatty acid composition of lipids in adipose tissue was per-
formed by Lipomics Technologies (West Sacramento,
USA). Briefly, lipids were extracted from 30 mg of frozen
epididymal adipose tissue in the presence of authentic
internal standards by the method of Folch et al. [27] using
chloroform:methanol (2:1, by vol.). After separation of
individual lipid classes by preparative thin-layer chroma-
tography, the TAG and PL were scraped and trans-esteri-
fied; the resulting fatty acid methyl esters were then
separated and quantified by capillary gas chromatography
as previously described [28].
Muscle
The frozen gastrocnemius muscle was thawed and thor-
oughly dissected under stereomicroscope to remove
extramyocellular adipose tissue. Lipids from lyophilized,
finely powdered, dissected muscle (50 mg) were extracted
according to the method of Folch [27]. PL (19:0), TAG
(17:0) and DAG (15:0) internal standards (Varian; Zug,
Switzerland) were added prior to lipid extraction. The lip-
ids were loaded on a Chromabond NH2 cartridge (Varian;
Zug, Switzerland), and neutral lipids were separated from
free fatty acids and PL by sequential elution with chloro-
form/2-Propanol (2:1), 2% acetic acid in diethylether and
methanol, respectively [29]. The neutral lipids were sub-
jected to thin-layer chromatography using hexane:diethyl-
ether:acetic acid (70:30:1, by vol.) as solvent system to
separate DAG from TAG [30]. The hydrolysis of TAG into
DAG during sample analysis has been assessed and repre-
sented less than 0.5% of total DAG. The fatty acids from
the phospholipids, TAG and DAG were converted to their
methyl esters. Fatty acid methyl-ester separation was per-
formed by automated gas-liquid chromatography (HP
6890 series) with FID detection (280°C); authentic stand-
ard mixtures of fatty acid methyl-esters (Nu-Chek-Perp;
Lowell Mutter, USA) were injected to identify fatty acid
methyl-ester peaks. Results are expressed in µmol fatty
acids per gram lyophilised muscle.
Plasma metabolites
Plasma glucose and insulin were determined with com-
mercially available kits purchased from Sigma (Buchs,
Switzerland) and Crystal Chem Inc. (Downers Grove,
USA), respectively. Plasma triglycerides and free fatty
acids concentrations were analysed using kits from Roche
Diagnostic (Basel, Switzerland) and Wako Chemicals
(Richmond, USA), respectively.
Statistical analysis
Comparisons of the means of the dependent variables of
each group were performed using a one-way ANOVA.
Results
Body weight and fat mass
Male Sprague-Dawley rats were fed, during 60 days, either
a chow diet used as a reference group (REF group), a cafe-
teria diet (CAF rats) or a cafeteria diet plus a daily gavage
of the β3-AR agonist ZD7114 (CAF-ZD rats).
At day 60, the mean body weight of CAF rats was signifi-
cantly greater than that of REF rats (Table 1). On the other
hand, CAF-ZD rats presented a significant reduction in
mean body weight when compared with CAF rats (Table
1). Similar effects were observed on weight gain which
was 46% greater in CAF rats than in REF rats (Figure 1;
213.2 ± 12.2 g vs. 312.3 ± 19.2 g in REF and CAF rats,
respectively; p < 0.01), and reduced by 17% in CAF-ZD
rats as compared to CAF rats (258.70 ± 12.70 g in CAF-ZD
rats, p < 0.05). The enhancement of body weight in CAF
rats was strongly associated with the weight increase of
two main deep adipose depots, confirming the obesigenic
properties of the cafeteria diet. Indeed, the epididymal
and retroperitoneal fat pads in CAF rats were respectively
131% and 185% heavier than those of REF rats (Table 1).
ZD7114 treatment decreased the weight of the two adi-
pose tissue depots by about 45%, compared to CAF rats
(Table 1). The weights of gastrocnemius skeletal muscle,
liver and heart were not different between groups (Table
1). As expected, CAF rats had a higher energy intake com-
pared with REF animals (106.03 ± 7.25 vs 78.49 ± 2.96
kcal/day). However, the anti-obesity effect of ZD7114 was
not attributed to a reduction of energy intake (107.70 ±
7.30 kcal/day in CAF-ZD rats).
Glucose and insulin plasma concentrations
Measurement of insulin and glucose concentrations in
plasma of fasted animals showed that CAF rats presented
a marked hyperinsulinemia with a 4.6 fold increase in
insulin concentration as compared to REF animals
whereas the glucose level was not changed (Table 1).
ZD7114 treatment limited the hyperinsulinemia induced
by the cafeteria diet, as demonstrated by the 2.3 fold
decrease in plasma insulin concentrations in CAF-ZD rats
compared with the CAF group (Table 1). No significant
changes in plasma glucose concentrations were observed
between these two groups (Table 1).
Adipose tissue lipids
Lipid content
PL and TAG contents per gram of tissue were measured in
epididymal adipose tissue of rats fed with a chow diet or
a cafeteria diet treated or not with ZD7114. No significant
change was observed in the concentration of PL and TAGNutrition & Metabolism 2004, 1:4 http://www.nutritionandmetabolism.com/content/1/1/4
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in adipose tissue of CAF rats when compared with REF
animals (Table 2). Furthermore, ZD7114 treatment did
not affect adipose tissue lipid content of CAF rats.
Fatty acid composition
Analysis of the fatty acid profile shows that cafeteria diet
induced an increase in the proportion of monounsatu-
rated fatty acids (MUFA), which was compensated for by
a reduction in the percentage of PUFA in both adipose PL
and TAG (Figure 2). Changes in the proportion of MUFA
in PL and TAG were mainly due to the increase of oleic
acid (1.7 and 2.0 fold increase in PL and TAG, respec-
tively; Table 3). Reduction in the percentage of linoleic
acid was mainly responsible for the decrease in propor-
tion of PUFA in both PL and TAG (1.6 and 2.3 fold
decrease for PL and TAG, respectively; Table 3). The pro-
portions of arachidonic and α-linolenic acids were also
slightly decreased in PL and TAG, respectively (Table 3).
Although the global proportion of SFA was not modified
in adipose tissue PL and TAG of CAF rats when compared
with REF animals, the percentage of myristic and stearic
acids were respectively enhanced in PL and TAG of CAF
animals.
ZD7114 treatment did not change the proportions of any
lipid classes measured in adipose TAG of CAF rats (Figure
2). However, in PL, the percentage of PUFA was signifi-
cantly increased by 1.3 fold in CAF-ZD rats compared to
CAF animals. This change was essentially due to a two-
fold increase in the proportion of arachidonic acid meas-
ured in CAF-ZD rats (Table 3). A slight reduction in the
percentage of myristic acid (1.2 fold decrease) was meas-
ured in CAF-ZD rats compared to CAF animals.
Skeletal muscle lipids
Lipid content
PL, diacylglycerol (DAG) and TAG contents were meas-
ured in the gastrocnemius of REF animals and CAF rats
with or without ZD7114 treatment (Table 4).
The cafeteria diet clearly induced TAG and DAG accumu-
lation in the gastrocnemius, as demonstrated by the
respective 3.4 and 2.0 fold increases observed in CAF vs.
REF rats (Table 4). Chronic treatment with ZD7114 did
not significantly reduce the cafeteria diet induced-accu-
mulation of TAG in muscle. In contrast, DAG accumula-
tion was prevented as indicated by a 1.5 fold reduction of
DAG levels in CAF-ZD when compared with CAF rats
(Table 4). Values of intramyocellular TAG and DAG
obtained in the present study (TAG: between 1 to 4 µmol/
g fresh muscle; DAG: between 0.5 to 1 µmol/g fresh mus-
cle) were similar to those previously described in rat
Table 1: Body weight, tissues and fasting plasma metabolites
REF CAF CAF-ZD
Final body weight (g) 443.78 ± 21.42 540.20 ± 16.69 * 477.82 ± 12.09 +
Retroperitoneal (g) 3.73 ± 0.44 10.65 ± 0.48 ** 5.78 ± 0.23 +
Epididymal (g) 4.65 ± 0.41 10.73 ± 0.43 ** 5.96 ± 0.30 +
Gastrocnemius (g) 2.69 ± 0.13 2.78 ± 0.01 2.79 ± 0.03
Heart (g) 1.25 ± 0.07 1.48 ± 0.01 1.46 ± 0.02
Liver (g) 13.53 ± 0.79 16.69 ± 0.15 15.47 ± 0.12
Glucose (mmol/l) 12.80 ± 1.51 12.10 ± 1.02 14.78 ± 1.11
Insulin (µU/ml) 19.75 ± 2.05 98.04 ± 16.01 ** 43.27 ± 8.26 +
Fatty acid (mmol/l) 0.47 ± 0.22 0.42 ± 0.68 0.30 ± 0.39 **
Triacylglycerol (mmol/l) 2.27 ± 0.30 4.59 ± 0.58 ** 4.11 ± 0.95
Data are the mean ± SEM. Values significantly different from those obtained in the group of rats fed a chow diet (REF) are indicated by * (p < 0.05) 
and ** (p < 0.01). Data measured in the group of rats treated with ZD7114 (CAF-ZD) and significantly different from those in the group of rats fed 
a cafeteria diet (CAF) are shown by + (p < 0.05).
Table 2: Adipose tissue lipid content
µmole/g tissue REF CAF CAF-ZD
Phospholipids 8.29 ± 1.28 10.59 ± 1.06 8.65 ± 0.87
Triacylglycerol 2476.34 ± 68.31 2462.63 ± 41.33 2271.57 ± 122.46
Data are the mean ± SEM. REF: rats fed a chow diet; CAF: rats fed a cafeteria die, CAF-ZD: rats fed a cafeteria diet and treated with ZD7114Nutrition & Metabolism 2004, 1:4 http://www.nutritionandmetabolism.com/content/1/1/4
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skeletal muscles [31] (TAG: between 4 to 5 µmol/g fresh
muscle; DAG: between 0.5 to 2.5 µmol/ g fresh muscle).
Fatty acid composition
Fatty acid profiles were determined in muscle PL, TAG and
DAG. The gastrocnemius of CAF rats, compared with the
REF group, presented an increase in the percentage of
MUFA and a decrease in the proportion of PUFA in both
TAG and DAG and to a lesser extent in PL (Figure 3).
Variations in the percentage of oleic and linoleic acids
were, respectively, responsible for the changes in the pro-
portions of MUFA and PUFA in muscle TAG and DAG
(Table 5). Modifications of the proportions of PUFA
observed in muscle PL of CAF rats were due to slight
decreases of both linoleic (1.4 fold increase) and docosa-
hexaenoic (22:6 n-3) acids (1.3 fold increase), whereas
the percentage of arachidonic acid (20:4 n-6) was
increased by 1.2 fold.
The influence of ZD7114 on the cafeteria-induced modi-
fication of fatty acid composition in the three lipid species
was evaluated by comparing CAF rats with CAF-ZD rats.
While ZD7114 did not affect the fatty acid profile of either
Individual weight changes Figure 1
Individual weight changes. Body weight was measured in rats 
(n = 5) fed a chow diet (REF) or a cafeteria diet alone (CAF) 
or treated with 1 mg/kg/day ZD7114 (CAF-ZD) at the begin-
ning and at the end of the different interventions (day 60). 
Data are represented as individual values.
Proportion of the different lipid classes in adipose tissue Figure 2
Proportion of the different lipid classes in adipose tissue. Sat-
urated (SFA), monounsaturated (MUFA) and polyunsaturated 
fatty acids (PUFA) were measured in epididymal adipose tis-
sue phospholipid (PL) and triacylglycerol (TAG) of rats fed a 
chow diet (empty bars) or a cafeteria diet (black bars) alone 
or treated with ZD7114 (grey bars). Data are represented as 
mean ± SEM, and values significantly different to data meas-
ured in rats fed the chow or cafeteria diets are indicated by * 
(p < 0.05), ** (p < 0.01) or + (p < 0.05), respectively.
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TAG or PL in muscle of CAF rats, it induced changes in the
fatty acid composition of muscle DAG. Indeed, the pro-
portion of SFA was slightly (1.2 fold increase), but signif-
icantly, elevated in DAG of CAF-ZD rats with an increase
in the proportion of palmitic and stearic acids (Table 5).
Furthermore, the proportion of MUFA in DAG of CAF-ZD
rat muscles was decreased compared with DAG of CAF
rats. This change was essentially attributed to a decrease in
the proportion of oleic acid (Table 5). Stearidonic acid
(18.4 n-3) was only detected in DAG accumulated in mus-
cles of ZD-CAF rats. No differences in the proportion of
PUFA between DAG stored in muscles of CAF-ZD or CAF
rats were observed (Figure 3).
Discussion
The present study demonstrates that feeding the cafeteria
diet to rats not only promotes weight gain, hyperinsuline-
mia and hypertriglyceridemia, but also accumulation of
lipids in skeletal muscle. Although TAG levels per gram of
adipose tissue was not affected by the cafeteria diet, this
dietary intervention strongly enhanced TAG accumula-
tion in skeletal muscle, as previously described [4,5]. We
show that this intramyocellular accumulation of TAG was
associated with an increase in skeletal muscle DAG con-
tent. This finding is in agreement with the accumulation
of DAG observed in human skeletal muscle cells incu-
bated with saturated fatty acids in vitro [12]. DAG mass
was also described to be increased in skeletal muscle biop-
sies obtained from normal volunteers in whom insulin
resistance was produced by raising FFA levels during a
lipid infusion [32]. However, to our knowledge, the
present study demonstrates for the first time that a high fat
diet, resembling the human Western diet, was able to
increase DAG storage in skeletal muscle. Although both
TAG and DAG accumulations in skeletal muscle were
reported to be correlated with insulin resistance [4,5,33],
DAG (a precursor of TAG synthesis) is proposed to
directly impair insulin sensitivity by inactivating insulin
receptor activity through activation of the protein kinase
C [34].
The fatty acid composition of TAG stored in muscle was
previously shown to be affected by dietary lipids [2]. Inter-
estingly, we also find that the fatty acid composition of
muscle DAG was modified by the cafeteria diet. Indeed,
the increase in MUFA and the reduction of PUFA propor-
tions, measured in both DAG and TAG, reflected the dif-
ference in lipid composition of the two diets (+ 19%
MUFA and -28% PUFA in cafeteria diet vs. chow diet). It
is noteworthy that qualitative changes in DAG were
reported to affect the activity of DAG as a secondary mes-
senger, since specificity of its fatty acyl moieties for the
activation of protein kinase C has been described [35,36].
Although measurements of insulin sensitivity were not
directly accessed in this study, our observation suggests
that diet may regulate insulin response in muscle by mod-
ifying DAG composition.
Fatty acid compositions of muscle and adipose tissue PL
were also modified by the cafeteria diet. More specifically,
the proportion of PUFA in PL was decreased and MUFA
was increased in both tissues. These differences were more
Proportion of the different lipid classes in muscle Figure 3
Proportion of the different lipid classes in muscle. Saturated 
(SFA), monounsaturated (MUFA) and polyunsaturated fatty 
acids (PUFA) were measured in muscle phospholipid (PL), 
triacylglycerol (TAG) and diacylglycerol (DAG) of rats fed a 
chow diet (empty bars), a cafeteria diet (black bars) alone or 
treated with ZD7114 (grey bars). Data are represented as 
mean ± SEM, and values significantly different to data meas-
ured in rats fed the chow or cafeteria diet are indicated by * 
(p < 0.05), ** (p < 0.01) or + (p < 0.05), ++ (p < 0.01), 
respectively.
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pronounced in PL from adipose tissue than from gastroc-
nemius, indicating that membrane phospholipids in adi-
pose tissue are more susceptible to variations in dietary
composition than skeletal muscle. Interestingly, reduc-
tions in the proportion of PUFA in PL from myocytes [7]
and adipocytes [8] were reported to impair insulin action.
As previously reported with Trecadrine, a selective β3-AR
agonist [22], chronic administration of ZD7114 pre-
vented the excess weight gain and fat accumulation
induced by a cafeteria diet. This present report
demonstrates that ZD7114 treatment reduced the hyper-
insulinemia elicited by the cafeteria diet (by 2.3 fold),
thereby suggesting an improvement of insulin sensitivity
in the treated rats. This observation was associated with a
significant reduction in the accumulation of skeletal mus-
cle DAG, and a slight, non-significant decrease in TAG. It
is tempting to suggest that the decrease in muscle DAG
accumulation induced by the chronic administration of a
β3-AR agonist could participate in the prevention of
hyperinsulinemia. β3-AR agonist treatment significantly
modified the fatty acid composition of DAG, causing a 1.2
fold reduction in the proportion of oleic acid. As men-
tioned before, these modifications in DAG composition
could directly regulate insulin action in muscles. Since the
presence of a β3-AR in skeletal muscle is still a subject of
debate, it is difficult to elucidate the mechanism(s) by
which the β3-AR agonist lowers DAG content in muscle
and modifies its fatty acid composition.
Although the content and the fatty acid composition of
TAG stored in adipose tissue was not affected by β3-AR
Table 3: Composition of adipose tissue lipids
% mole fatty acids REF CAF CAF-ZD
Phospholipids
Myristic acid (14:0) 3.04 ± 0.16 3.81 ± 0.19 * 2.96 ± 0.15 ++
Palmitic acid (16:0) 28.70 ± 3.10 30.72 ± 1.83 26.22 ± 1.70
Stearic acid (18:0) 15.99 ± 1.19 16.10 ± 0.75 16.93 ± 0.50
Palmitoleic acid (16:1n-7) 1.17 ± 0.28 1.35 ± 0.31 1.16 ± 0.29
Oleic acid (18:1n-9) 10.74 ± 0.94 18.17 ± 1.60 ** 16.26 ± 1.39 *
Vaccenic acid (18:1n-7) 1.24 ± 0.12 0.89 ± 0.07 * 0.98 ± 0.10
Linoleic acid (18:2n-6) 21.21 ± 1.98 13.27 ± 1.20 ** 16.41 ± 1.55 *
Eicosadienoic acid (20:2n-6) 2.16 ± 1.37 0.92 ± 0.92 0.37 ± 0.37
Arachidonic acid (20:4n-6) 7.69 ± 0.73 4.47 ± 1.23 * 8.90 ± 1.35 +
Triacylglycerol
Myristic acid (14:0) 1.23 ± 0.03 1.33 ± 0.08 1.39 ± 0.28
Palmitic acid (16:0) 21.80 ± 0.29 21.48 ± 0.63 21.02 ± 0.65
Stearic acid (18:0) 3.35 ± 0.15 5.27 ± 0.35 ** 4.84 ± 1.68 *
Palmitoleic acid (16:1n-7) 2.50 ± 0.27 2.29 ± 0.34 2.44 ± 0.46
Oleic acid (18:1n-9) 24.37 ± 1.04 48.87 ± 1.35 ** 47.09 ± 0.20 **
Vaccenic acid (18:1n-7) 1.98 ± 0.12 1.59 ± 0.12 1.73 ± 1.20
Linoleic acid (18:2n-6) 38.22 ± 1.36 16.59 ± 0.72 ** 18.37 ± 0.16 **
α-linolenic acid (18:3n-3) 2.85 ± 0.16 0.67 ± 0.06 ** 0.71 ± 0.20 **
Data are the mean ± SEM. Values significantly different from those obtained in the group of rats fed a chow diet (REF) are indicated by * (p < 0.05) 
and ** (p < 0.01). Data measured in the group of rats treated with ZD7114 (CAF-ZD) and significantly different from those in the group of rats fed 
a cafeteria diet (CAF) are shown by + (p < 0.05) and ++ (p < 0.05). Only main fatty acids are presented. CAF-ZD: rats fed a cafeteria diet and 
treated with ZD7114.
Table 4: Muscle lipid content
µmole/g tissue REF CAF CAF-ZD
Phospholipids 60.31 ± 4.28 65.62 ± 1.26 70.80 ± 2.77
Triacylglycerol 5.40 ± 0.98 18.63 ± 3.24 ** 15.65 ± 2.57 **
Diacylglycerol 2.07 ± 0.32 4.08 ± 0.24 ** 2.66 ± 0.25 ++
Data are the mean ± SEM. Values significantly different from those obtained in the group of rats fed a chow diet (REF) are indicated by ** (p < 0.01). 
Data measured in the group of rats treated with ZD7114 (CAF-ZD) and significantly different from those in the group of rats fed a cafeteria diet 
(CAF) are shown by ++ (p < 0.05).Nutrition & Metabolism 2004, 1:4 http://www.nutritionandmetabolism.com/content/1/1/4
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agonist administration, the fatty acid profile of adipose PL
was modified by the treatment. The β3-AR agonist was
able to restore the proportion of PUFA to a level similar to
the REF rats by increasing the percentage of arachidonic
acid by 2 fold. As mentioned above, a greater percentage
of PUFA in PL has been reported to enhance insulin
sensitivity in adipose tissue. The changes in PL composi-
tion induced by the β3-AR agonist may be associated with
the previously reported improved insulin sensitivity in
adipose tissue [8], and the decrease of hyperinsulinemia
measured in the present study.
Conclusions
Whilst the effectiveness of β3-AR agonists is limited in
humans, understanding the metabolic changes affected in
rodents will provide insights into mechanisms, underly-
ing insulin responsiveness in humans. The present study
demonstrates that β3-AR agonist treatment not only limits
the hyperinsulinemia induced by a cafeteria diet, but also
partially prevents the associated alterations in adipose
and muscle lipid composition. Particularly, activation of
the β3-AR limits the intramyocellular DAG accumulation
and the decrease in the proportion of PUFA in adipose
tissue PL. This combined action may contribute to the
beneficial effect of β3-AR agonists on insulin sensitivity.
List of abbreviations
CAF rats: Rats fed with a cafeteria diet; DAG: Diacylglyc-
erol;  MUFA: Monounsaturated fatty acid; PKC: Protein
kinase C; PUFA: Polyunsaturated fatty acid; REF rats: Rats
fed with a chow diet; SFA: saturated fatty acid. TAG: Tria-
cylglycerol; ZD-CAF rats: Rats fed with a cafeteria diet and
treated with the β3-AR agonist ZD7114.
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